Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis.

about

One- and two-sample t tests.

P2860

Q48226887-459F743A-6BF1-49CD-BA51-1D9D437A0976

P2860

Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis.

Item

http://www.wikidata.org/entity/Q39177577

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Patients' outcome after rescue ...... center retrospective analysis.

@en

Patients' outcome after rescue ...... center retrospective analysis.

@nl

type

Item

label

Patients' outcome after rescue ...... center retrospective analysis.

@en

Patients' outcome after rescue ...... center retrospective analysis.

@nl

prefLabel

Patients' outcome after rescue ...... center retrospective analysis.

@en

Patients' outcome after rescue ...... center retrospective analysis.

@nl

P1476

Patients' outcome after rescue ...... center retrospective analysis.

@en

P2093

Angela M Krackhardt

http://www.w3.org/2001/XMLSchema#string

Christian Peschel

http://www.w3.org/2001/XMLSchema#string

Dagmar Wäscher

http://www.w3.org/2001/XMLSchema#string

Katharina Götze

http://www.w3.org/2001/XMLSchema#string

Mareike Verbeek

http://www.w3.org/2001/XMLSchema#string

Robert Peter

http://www.w3.org/2001/XMLSchema#string

Silvia Spoerl

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients

The incidence of tumor cell contamination of peripheral blood stem cells: a meta-analysis to evaluate the impact of mobilization regimens and the influence on outcomes in breast cancer patients.

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Relevance and clinical implications of tumor cell mobilization in the autologous transplant setting.

Long-term experiences in cryopreservation of mobilized peripheral blood stem cells using a closed-bag system: a technology with potential for broader application.

Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.

Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.

Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients.

P304

115-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.13883

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27859332

http://www.w3.org/2001/XMLSchema#string

Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis.

about

P2860

P2860

Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698